Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UPDATE: Schumer Says Senate Bipartisan Infrastructure Bill Will Not Include Enough For Human Infrastructure

-Reuters

byBenzinga Newsdesk

June 15, 2021

1 minute read

-Reuters

Interim Results Of NanoVibronix’s Uroshield Show Beneficial Effects For Patients

By Vandana Singh

Today, 5:15 AM

NanoVibronix Inc (NASDAQ:NAOV) announced interim results of its U.K. clinical study for UroShield, a disposable ultrasound device that reduces biofilm contaminating the…

NAOV

Abeona Therapeutics Announces Clinical Data Presentations At Upcoming Scientific Congresses

By Bill Haddad

Today, 5:15 AM

Abeona Therapeutics Inc. (NASDAQ:ABEO), a fully-integrated leader in gene and cell therapy, today announced two presentations of previously disclosed clinical data at upcoming scientific congresses in October 2021.

ABEO

Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy Trial

By Vandana Singh

Today, 5:15 AM

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) has announced interim data updates from seven patients from the RP-L201 Phase 1/2 trial for Leukocyte Adhesion…

RCKT

ABM Industries Hikes Dividend By 12.8%

By Shivani Kumaresan

Today, 5:15 AM

ABM Industries Inc (NYSE:ABM) Board of Directors has approved a quarterly cash dividend of $0.22 per common share. The new…

ABM

UPDATE: Schumer Says Senate Bipartisan Infrastructure Bill Will Not Include Enough For Human Infrastructure

Related Posts

Interim Results Of NanoVibronix’s Uroshield Show Beneficial Effects For Patients

Abeona Therapeutics Announces Clinical Data Presentations At Upcoming Scientific Congresses

Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy Trial

ABM Industries Hikes Dividend By 12.8%